NeuroPace Inc

NPCENASDAQ · USD
14.06USD0.00 (+0.65%)
369

NeuroPace Inc (NPCE) Covered Calls

As of September 25, 2026, NPCE has 6 covered call opportunities in the coming three months. Return ranges from 10.6 to 44.0% until expiration. Annualized return ranges from 28.8 to 184.2%. The nearest expiration is October 16, 2026. Maximum potential profit is $619.

Read more

Running NPCE covered calls helps you generate consistent income from NeuroPace Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on NeuroPace Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best NPCE covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if NPCE stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling NPCE covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given NeuroPace Inc covered call is worth writing.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Income-focused investors, long-term NPCE holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling NPCE covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best NeuroPace Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile69.84% Elevated
  • Market cap (M$)483
  • 52 weeks high-28.27%
  • 52 weeks low52.49%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$20.00
    42.25% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.57
  • EPS growth next 5 years35.76%

As of September 25, 2026

2026-10-162115.006.690.552.00149.0010.60184.19-3.91+0.47571.45
2027-02-1914720.0042.250.251.10619.0044.03109.32-1.78+0.25800.85
2027-05-2123820.0042.250.253.00619.0044.0367.52-1.78+0.3902.75
2027-02-1914717.5024.470.102.00354.0025.1862.52-0.71+0.3631.90
2027-05-2123817.5024.471.253.50469.0033.3651.16-8.89+0.4902.25
2027-05-2123815.006.691.704.30264.0018.7828.80-12.09+0.5902.60

As of September 25, 2026

Sell covered calls with the data behind you

Find the best NPCE covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial